In conclusion, our newly established bi-inducible breast cancer cellular model is of broad interest since it allows mechanistic understanding of how target cells behave with PR ligand and with other PR activators such as EGF under normal and pathological contexts. This evidence concerns the gene EGF and breast cancer.